CytoMed Therapeutics Ltd SEC Filing (Aug 11, 2026)
This article reports on CytoMed Therapeutics Ltd's (GDTC) SEC Form 144 filing from August 11, 2026. The filing indicates a proposed sale of securities under Rule 144, detailing information about the issuer, securities to be sold (Ordinary Shares acquired on 04/22/2021), and the transaction …